An Update on the Fixed-Dose Combination Topical Corticosteroid/Vitamin D3 Analogue (Betamethasone Dipropionate-Calcipotriol) for Plaque Psoriasis

Abstract

Plaque psoriasis is a chronic, recurrent, immune-mediated, inflammatory skin disease that can have a significant negative impact on patient and family quality of life. The therapeutic landscape for this condition has evolved considerably over the past two decades, with many novel treatments receiving approval in Canada and other countries around the world. Despite these advances, which include targeted systemic therapies that are allowing patients to achieve higher levels of skin clearance, topical therapies remain a mainstay in the management of plaque psoriasis.